mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.4 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |